After IAP exit, Hyderabad paediatrician Sivaranjani Santosh alleges pharma influence, seeks probe into ORSL promotion

Account subscription benefits alongside Premium Stories, Editorials, Opinions and more. Unlock these with Subscription

The View From India Looking at World Affairs from the Indian perspective.

First Day First Show News and reviews from the world of cinema and streaming.

Today's Cache Your download of the top 5 technology stories of the day.

Data Point Decoding the headlines with facts, figures, and numbers

Health Matters Ramya Kannan writes to you on getting to good health, and staying there

The Hindu On Books Books of the week, reviews, excerpts, new titles and features.

Hyderabad-based paediatrician Dr Sivaranjani Santosh has said that her resignation from the Indian Academy of Paediatrics (IAP), which she submitted nearly two months ago, has now been formally accepted by the organisation.

In a post on social media platform X, Dr Santosh said that the acceptance of her resignation had freed her from any obligation to remain restrained in criticising the academy’s leadership. “So far, I had to show some restraint before calling the leadership out for their pathetic slavery to pharma. Now, I am under no obligation to show that restraint,” she wrote.

The paediatrician alleged that while the IAP had previously been led by ethical leaders who helped the organisation achieve significant milestones, its leadership in recent years had prioritised pharmaceutical funding over child safety. She said she was relieved to have exited the organisation.

Dr Santosh also called upon the National Medical Commission (NMC) and the Union Ministry of Health and Family Welfare to investigate what she described as the continued presence of stalls promoting ORSL, a hydration drink marketed by Johnson and Johnson’s consumer health business Kenvue, at PEDICON conferences organised by the IAP.

According to her, she had repeatedly brought the issue to the attention of the IAP leadership but no action was taken. She alleged that ORSL, which contains higher sugar levels than standard World Health Organisation (WHO) recommended oral rehydration solution (ORS), was being promoted and sold in schools, pharmacies and hospitals in a manner that could mislead consumers into believing it was equivalent to ORS.

Dr Santosh further alleged that parents were not adequately informed about the risks associated with the routine consumption of sucralose-containing beverages by children. She also questioned why the professional body had allowed Kenvue to claim that its products had been scientifically presented at PEDICON conferences without facing any condemnation from the organisation.